Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
Riku Pihlanto / City of Helsinki
Jun 28, 2023

Helsinki deep tech startup Algorithmiq secures EUR14M for drug development with quantum computing

Finnish deep tech company Algorithmiq completed a EUR 14 million financing round to further develop quantum computing algorithms for life sciences. The algorithms can be used to accelerate and optimise drug development by simulating the chemical activity of molecules.

Helsinki-based Algorithmiq’s approach is aimed at radically improving both the development time and cost of drug development by skillfully combining the power of quantum algorithms, network medicine, and AI for structure prediction, molecular similarity simulation, and realistic modeling of protein-ligand docking. The company’s quantum chemistry platform Aurora sits on top of leading vendors.

Recently, the company announced a collaboration with IBM to super-charge the exploration of quantum algorithms applied to the life sciences.

The investment round was led by Nordic early-stage fund Inventure, with Finland’s state-owned investment company Tesi, Presidio Ventures, Thames Trust and existing investors participating.

Recently, Algorithmiq announced a collaboration with IBM.

“We think Helsinki-based Algorithmiq will be the key player to solve this [quantum] noise challenge. … The beauty of Algorithmiq’s solution is that it is hardware agnostic, meaning it can run on any quantum device regardless of how it’s built,” says Lauri Kokkila, Partner at Inventure in Inventure’s blog.

The Algorithmiq team, led by CEO and Co-founder Prof. Sabrina Maniscalco, comprises of University of Turku, University of Helsinki and Aalto University researchers. The company is currently looking to hire more.

”We are excited to support Algorithmiq’s ambitious world-class team. Drug discovery is one of the most impactful application areas for quantum computing, and Algorithmiq has already demonstrated impressive technical results,” says Joni Karsikas, Investment Director at Tesi.

Algorithmiq website

More news

Health Capital Helsinki

Friends having a picnic at Helsinki city centreAleksi Poutanen / Helsinki Partners

Best health data in the world: Take a look at Finland

Sep 18, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/05/Picnic_cathedral_park_AleksiPoutanen-e1692796048807.jpg 800 1200 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-09-18 09:56:322023-09-18 11:55:08Best health data in the world: Take a look at Finland
Ambulance on the way to hospitalUnsplash

AI in healthcare – Helsinki leading the way

Sep 15, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/05/camilo-jimenez-vGu08RYjO-s-unsplash-scaled-e1680504719542.jpg 1000 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-09-15 10:44:012023-09-18 11:51:42AI in healthcare – Helsinki leading the way
Decorative image of DNAPixabay

Health Incubator Helsinki startup AarogyaAI predicts antimicrobial resistance

Sep 12, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/09/header_image_dna.jpg 844 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-09-12 07:00:512023-09-11 16:14:27Health Incubator Helsinki startup AarogyaAI predicts antimicrobial resistance
All news

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences .

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice